OR12D2 is a 307-amino acid protein encoded by the OR12D2 gene (Gene ID: 26529) located on chromosome 6p22.1 . Its structure includes:
Seven transmembrane domains (TM1–TM7), characteristic of GPCRs .
Partial or full-length constructs, depending on production systems (e.g., E. coli or yeast) .
| Property | Detail |
|---|---|
| Gene Location | Chromosome 6p22.1 (NC_000006.12) |
| Alternative Names | Hs6M1-20, Olfactory Receptor OR6-28 |
| Uniprot ID | P58182 |
Storage:
OR12D2 is utilized in:
Ligand screening to identify odorant agonists (no physiological ligands confirmed) .
Calcium imaging assays to study signaling pathways in olfactory cells .
Exome-wide studies in Saudi females identified OR12D2 variants as risk factors for ASD:
SNPs: rs2073154C, rs2073153T, rs2073151G (linked to OR5V1 via high LD) .
Mechanism: Olfactory receptor dysfunction may impair neurodevelopmental signaling, contributing to ASD phenotypes .
While OR12D2 itself is not directly implicated in sperm function, related olfactory receptors (e.g., OR2H1/2, OR10J1) show localized expression in sperm compartments, suggesting potential roles in chemotaxis or fertilization .
Segregating pseudogene: Some alleles encode functional receptors, while others are non-functional due to mutations .
Linkage disequilibrium (LD): Limited LD with MHC genes on chromosome 6, reducing evolutionary pressures for haplotype conservation .
Olfactory Receptor 12D2 (OR12D2) is a G protein-coupled receptor belonging to the olfactory receptor family. It is also known by alternative names including Hs6M1-20 and Olfactory receptor OR6-28. The gene is located on chromosome 6, where it clusters with other olfactory receptor genes including OR11A1 and OR10C1, with which it shares high linkage disequilibrium . The UniProt ID for OR12D2 is P58182 . The full-length human OR12D2 protein consists of 307 amino acids and functions as a chemosensory receptor that detects odorant molecules in the olfactory epithelium, triggering neuronal responses that ultimately lead to the perception of smell.
Two primary expression systems have been documented for recombinant OR12D2 production:
| Expression System | Tag | Protein Length | Purity | Source |
|---|---|---|---|---|
| E. coli | N-terminal His tag | Full-length (1-307) | >90% (SDS-PAGE) | |
| Baculovirus | Variable (determined during manufacturing) | Partial | >85% (SDS-PAGE) |
Each system offers distinct advantages. The E. coli system typically provides higher yields and is more cost-effective but may present challenges with proper folding of membrane proteins. The Baculovirus system often produces proteins with more native-like post-translational modifications and proper folding, which can be crucial for functional studies of GPCRs like OR12D2 .
For optimal stability and activity retention, recombinant OR12D2 requires specific storage and handling conditions:
Storage Temperature: Store at -20°C or -80°C for long-term storage
Buffer Composition: Typically stored in Tris/PBS-based buffer with 6% Trehalose, pH 8.0
Glycerol Addition: Addition of 5-50% glycerol (final concentration) is recommended for freeze-thaw stability
Aliquoting: Create working aliquots to avoid repeated freeze-thaw cycles
Working Storage: For short-term use, store working aliquots at 4°C for up to one week
Shelf Life: Liquid form typically has a shelf life of 6 months at -20°C/-80°C; lyophilized form has a shelf life of 12 months
Repeated freezing and thawing should be avoided as this can significantly degrade protein quality and functional activity .
When designing cell-based assays to investigate OR12D2 function:
Cell Line Selection: Choose heterologous expression systems that support GPCR trafficking and signaling (e.g., HEK293 cells)
Receptor Expression Construct: Include trafficking enhancers (e.g., N-terminal tags) that improve surface expression
Signaling Components: Co-express necessary G proteins (typically Gαolf for ORs) and other signaling components
Response Measurement: Incorporate calcium indicators or cAMP sensors to detect receptor activation
Controls: Include positive controls (known responding ORs) and negative controls (non-responding ORs or empty vector)
Dose-Response Analysis: Test odorants across a concentration range (typically 1 nM to 1 mM)
These assays have successfully demonstrated OR12D2's response to 2-ethylfenchol, providing a mechanistic explanation for genetic associations with perception .
OR12D2 exists in a genomic cluster with OR11A1 and OR10C1 on chromosome 6, with high linkage disequilibrium (>60% correlation in the 1000 Genomes Project EUR superpopulation data) . This creates significant challenges for genetic association studies. To overcome these limitations:
Functional Validation: Utilize cell-based assays to directly test each receptor's response to the odorant of interest
Fine Mapping: Perform detailed haplotype analysis across the genomic region
Cross-Population Studies: Leverage different linkage patterns across diverse populations
CRISPR-Based Approaches: Use gene editing to modify specific receptors and test phenotypic effects
Expression Analysis: Correlate receptor expression levels with genotype and perception
These approaches helped researchers determine that OR12D2 was functionally responsive to 2-ethylfenchol in vitro, distinguishing it from nearby ORs that showed significant genetic association due to linkage disequilibrium .
Research has demonstrated meaningful correlations between OR12D2 genetic variation and olfactory perception:
Odor Intensity: Genetic variations in OR12D2 correlate with changes in the perceived intensity of specific odorants, particularly 2-ethylfenchol
Pleasantness Perception: Genetic variations also influence the subjective pleasantness ratings of certain odorants
Loss of Function Effects: Loss-of-function variants in OR12D2 appear to alter both intensity and pleasantness perception of specific odorants
Receptor Functionality: In vitro assays confirm that OR12D2 responds to odorants that show genetic association with perception
These findings suggest that OR12D2 plays a direct role in the perception of specific odorants, and that genetic variation in this receptor contributes to individual differences in olfactory perception .
The relationship between in vitro receptor activation and in vivo perception requires careful interpretation:
Enrichment of Functional Receptors: ORs that respond in vitro are enriched in the set of receptors that are perceptually relevant, suggesting that in vitro assays can identify behaviorally important receptors
Expression Correlation: Functionally responsive ORs (including OR12D2) are more likely to be expressed in the human olfactory epithelium
Expression Level Significance: Deorphanized or perceptually relevant ORs are expressed at 1.5-fold higher levels than other intact ORs (P < 0.0001 via binomial test)
Predictive Value: Cell-based assays provide valuable evidence for validating genetic associations, with a higher hit rate (approximately 30% based on the studies) than expected by chance (approximately 12%)
These observations suggest that cell-based assays are a useful proxy for identifying behaviorally relevant ORs that are expressed in the olfactory epithelium and whose activation can be directly tied to perception .
When analyzing genetic association data for OR12D2:
Linkage Disequilibrium Correction: Account for the high linkage disequilibrium with nearby ORs (OR11A1, OR10C1)
False Discovery Rate Control: Implement appropriate multiple testing corrections (the referenced study had an FDR of 66% for their top 50 associations)
Functional Validation: Complement statistical associations with in vitro functional data
Effect Size Estimation: Quantify the magnitude of effect for different genetic variants on perception
Population Stratification: Control for potential confounding from population structure in diverse cohorts
Haplotype Analysis: Consider analyzing haplotypes rather than individual SNPs to capture combined effects
These approaches help distinguish true positive associations from false positives and overcome the challenges posed by the genomic architecture of olfactory receptor gene clusters .
To ensure high-quality recombinant OR12D2 for research applications:
Purity Assessment: Verify protein purity via SDS-PAGE (>90% for E. coli-derived protein, >85% for Baculovirus-derived protein)
Identity Confirmation: Confirm protein identity via western blot or mass spectrometry
Proper Reconstitution: For lyophilized protein, ensure proper reconstitution to a concentration of 0.1-1.0 mg/mL
Stability Verification: Validate protein stability after reconstitution and storage
Functional Testing: When possible, verify functional activity in an appropriate assay system
Storage Compliance: Store according to recommended conditions (with appropriate glycerol concentration, aliquoting, and temperature)
Implementing these quality control measures helps ensure that experimental findings are reliable and reproducible .
When OR12D2 fails to show expected responses in functional assays:
Protein Integrity: Verify the integrity of the receptor using SDS-PAGE and western blot
Surface Expression: Confirm proper trafficking to the cell surface using surface labeling techniques
Signaling Components: Ensure all necessary signaling components (G proteins, RTP1S, etc.) are present
Assay Sensitivity: Validate assay sensitivity using positive controls (known receptor-ligand pairs)
Concentration Range: Test a wider concentration range of odorants (typically 1 nM to 1 mM)
Buffer Composition: Optimize buffer composition for receptor stability and function
Expression Level: Verify expression level through qPCR or western blot analysis
These troubleshooting steps can help identify and address issues that may prevent successful detection of OR12D2 responses in functional assays .